NC

Nexthera Capital Portfolio holdings

AUM $120M
1-Year Est. Return 10.01%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+10.01%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$82.4M
AUM Growth
-$69.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$5.56M
2
+$2.73M
3
+$2.68M
4
ACOR
Acorda Therapeutics
ACOR
+$2.32M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.01M

Top Sells

1
+$24.3M
2
+$14.7M
3
+$14.4M
4
HRTX icon
Heron Therapeutics
HRTX
+$11.3M
5
BHC icon
Bausch Health
BHC
+$11M

Sector Composition

1 Healthcare 92.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
$9.78M 11.87%
250,620
-513,573
HRTX icon
2
Heron Therapeutics
HRTX
$176M
$9.5M 11.53%
388,623
-430,541
INSM icon
3
Insmed
INSM
$30.4B
$8.26M 10.03%
284,263
-554,683
IMMU
4
DELISTED
Immunomedics Inc
IMMU
$6.43M 7.8%
334,724
-559,955
BHC icon
5
Bausch Health
BHC
$2.01B
$5.08M 6.16%
205,660
-459,177
URGN icon
6
UroGen Pharma
URGN
$954M
$4.9M 5.94%
+132,589
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.61M 5.59%
87,099
-134,563
STML
8
DELISTED
Stemline Therapeutics, Inc.
STML
$4.18M 5.08%
325,526
-386,032
NVS icon
9
Novartis
NVS
$305B
$3.83M 4.65%
50,587
-302,200
AMRN
10
Amarin Corp
AMRN
$291M
$3.09M 3.75%
+7,435
CBAY
11
DELISTED
Cymabay Therapeutics
CBAY
$2.79M 3.39%
210,257
-504,507
SRPT icon
12
Sarepta Therapeutics
SRPT
$1.67B
$2.54M 3.08%
+21,270
QURE icon
13
uniQure
QURE
$896M
$2.31M 2.81%
+38,800
EXEL icon
14
Exelixis
EXEL
$10.7B
$2.15M 2.61%
90,356
-217,383
NBIX icon
15
Neurocrine Biosciences
NBIX
$12.8B
$2.12M 2.57%
+24,040
ACOR
16
DELISTED
Acorda Therapeutics
ACOR
$2.06M 2.5%
+1,290
AGN
17
DELISTED
Allergan plc
AGN
$2.01M 2.43%
+13,700
ICPT
18
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.34M 1.62%
+11,952
KNSA icon
19
Kiniksa Pharmaceuticals
KNSA
$3.54B
$1.22M 1.48%
+67,692
CHMA
20
DELISTED
Chiasma, Inc. Common Stock
CHMA
$1.06M 1.29%
203,948
-862,491
DCPH
21
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$995K 1.21%
42,865
-79,027
SAGE
22
DELISTED
Sage Therapeutics
SAGE
$986K 1.2%
+6,200
BMRN icon
23
BioMarin Pharmaceuticals
BMRN
$11.6B
$733K 0.89%
+8,250
MDGL icon
24
Madrigal Pharmaceuticals
MDGL
$9.72B
$432K 0.52%
+3,452
GYRE icon
25
Gyre Therapeutics
GYRE
$731M
– –
-50,135
1
2